October 19, 2025 · Read time: under 6 minutes
AIxBiotech – weekly brief
Reporting from Zug, Switzerland — Europe’s biotech hub
Presented by OUR SPONSOR
Traveling with Swiss or Lufthansa group?
With the Uptrip app you collect cards per flight which you can exchange for lounge access, points, miles, and even Frequent Flyer status. Referral code: AL-8B866938-E147. Sign up for free via this link, use referral code: AL-8B866938-E147 and start with 4 cards.
This week’s Biotech meets AI
3 headlines to be aware of
1. 🦠 Takeda × Nabla Bio scale AI-native biologics design.
Takeda deepens its alliance with Boston-based Nabla Bio, leveraging the JAM AI platform to design new protein therapeutics. The multi-year deal could exceed $1 billion in milestones — proof that generative AI is entering mainstream discovery pipelines.
🔗 Read more at Reuters
2. 🧠 AI meets immunotherapy at Insilico Medicine
Hong Kong-based Insilico reported the first AI-discovered small-molecule candidate entering Phase II for idiopathic pulmonary fibrosis — a global first that could set a regulatory precedent for fully AI-originated assets.
🔗 Read more at Insilico
3. 🧬 Tempus AI launches precision-trial matching with Eli Lilly
Their new collaboration links oncology datasets and EHR data to accelerate patient enrollment; early pilots cut screening time by 35%.
🔗 Read more at Yahoo Finance
From the Biotech Frontier
➤ Hansoh Pharma × Roche — The companies signed a licensing pact worth $1.45 billion for a colorectal-cancer therapy, marking another major China-to-global play.
➤ BillionToOne IPO filing — The diagnostics startup filed for a U.S. IPO targeting a $2.4 billion valuation, signaling renewed investor appetite for genomics-AI hybrids.
➤Rani Therapeutics × Chugai Pharma — Rani inked a $1.09 billion licensing deal for an oral antibody formulation; if successful, its capsule platform could redefine biologic delivery routes
AI Academy: The slide whisperer prompt
When you’re buried in 30-slide PowerPoints or monthly KPI decks, use this prompt to turn dense data into a crisp, exec-level summary slide:
“Turn this data or meeting summary into one PowerPoint slide titled ‘Key Takeaways – [Topic].’
Group insights into 3 short bullets: (1) impact, (2) risk, (3) next step.
Suggest a chart type if useful, and write a 1-sentence headline I can paste at the top.”
💡 Works perfectly with Copilot, ChatGPT, or PowerPoint Designer — you get content that fits your company tone and saves at least an hour of formatting.
⚙️ AI Tools: Work smarter not harder
1️⃣ 🧠 Ellie.ai — Turns raw datasets into story-ready slide decks with charts and summaries. Perfect for monthly KPI reviews.
🔗 ellie.ai
2️⃣ ⚙️ Taskade — Collaborative workspace that now includes multi-agent AI planners for project outlines and meeting follow-ups.
🔗 taskade.com
3️⃣ 📬 Flowrite — Chrome extension that converts rough bullet points into polished emails in your tone and style.
🔗 flowrite.com
Partner with AIxBiotech
Reach biotech operators and leaders across Europe and the US. Sponsor a section or run a product spotlight.